WHC is still in active development. Read this to understand our approach.
depiction of VCHHHSMPMLNVGS-UHFFFAOYSA-N.svg
psychonaut

JWH-073

Verificar en psychonaut

isomerdesign

JWH-073

Verificar en isomerdesign

pubchem

1-Butyl-3-(1-naphtho...

Verificar en pubchem

wiki

JWH-073

Verificar en wiki

Data

InChI: InChI=1S/C23H21NO/c1-2-3-15-24-16-21(19-12-6-7-14-22(19)24)23(25)20-13-8-10-17-9-4-5-11-18(17)20/h4-14,16H,2-3,15H2,1H3

Sinónimos: JWH-073; JWH073,PDSP1_000254,CCG-208716,CHEBI:181123,(1-butyl-1H-indole-3-yl)-1-naphthalenyl methanone,Q423476,1-Butyl-3-(1-naphthoyl) indole,DEA No.7173,JWH-073 (methanol solution),UNII-BBX3BP2772,1-naphthalenyl(1-butyl-1h-indol-3-yl)methanone,J2.856.750B,(1-butylindol-3-yl)-naphthalen-1-ylmethanone,CS-0827,A14167,PDSP2_000253,(1-butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone;JWH-073,doi:10.14272/VCHHHSMPMLNVGS-UHFFFAOYSA-N.1,Naphthaten-1-yl-(1-butylindol-3-yl)methanone,(1-Butyl-1h-Indol-3-Yl)(Naphthalen-1-Yl)Methanone,C23H21NO,(1-BUTYL-1H-INDOLE-3-YL)(NAPHTHALENE-1-YL)METHANONE,JWH073,SCHEMBL11983320,987B488,BCP24000,JWH-073,DTXSID20175042,1-Butyl-3-(1-naphthoyl)-1H-indole,CHEMBL2380416,FT-0664155,(1-Butylindol-3-yl)naphthalen-1-ylmethanone,AKOS005146537,10.14272/VCHHHSMPMLNVGS-UHFFFAOYSA-N.1,NA-BIMO,N-Butyl-3-(1-naphthoyl)indole,naphthalen-1-yl-(1-butylindol-3-yl)methanone,NCGC00378993-02,Methanone, (1-butyl-1H-indol-3-yl)-1-naphthalenyl-,HSDB 7999,208987-48-8,928046-68-8,1-Naphthyl(1-butyl-1H-indole-3-yl)methanone,FT-0664154,ACT06672,1-Butyl-3-(1-naphthoyl)indole,JWH 073,BDBM85804,CTDP-32476 HCl,HY-32733,A4544,ZINC38928174,BBX3BP2772,JWH-073 solution, 100 mug/mL in acetonitrile, ampule of 1 mL, (Spice Cannabinoid), certified reference material

Market name: jwh-073


Estimated data

Solubilidad: -6.396 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 99.4% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.